In 2024, the Indian pharma industry experiences exponential growth, fueled by factors like innovation, globalization, and increased healthcare demands. Third-party contract manufacturing emerges as a pivotal driver, offering scalability and cost-effectiveness to pharmaceutical companies. Unimarck Pharma, with over 40 years of manufacturing expertise, stands as a beacon of reliability in this landscape.
No comments:
Post a Comment